James Investment Research Inc Pfizer Inc Transaction History

James Investment Research Inc

$827 Million
Q2 2024

A detailed history of James Investment Research Inc transactions in Pfizer Inc stock. As of the latest transaction made, James Investment Research Inc holds 31,880 shares of PFE stock, worth $945,560. This represents 0.11% of its overall portfolio holdings.

Number of Shares

31,880

Holding current value

$945,560

% of portfolio

0.11%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$25.26 - $29.6 $805,288 - $943,648	31,880 New	31,880 $892,000
Q3 2023 Oct 31, 2023	SELL	$32.09 - $37.51 $631,659 - $738,346	-19,684 Reduced 41.26%	28,026 $929,000
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $41,285 - $47,765	-1,143 Reduced 2.34%	47,710 $1.75 Million
Q1 2023 Apr 25, 2023	SELL	$39.39 - $51.28 $196 - $256	-5 Reduced 0.01%	48,853 $1.99 Million
Q4 2022 Jan 30, 2023	SELL	$41.75 - $54.5 $9,393 - $12,262	-225 Reduced 0.46%	48,858 $2.5 Million
Q3 2022 Oct 31, 2022	SELL	$43.76 - $53.42 $43,103 - $52,618	-985 Reduced 1.97%	49,083 $2.15 Million
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $3,768 - $4,468	81 Added 0.16%	50,068 $2.63 Million
Q1 2022 Apr 22, 2022	BUY	$45.75 - $56.69 $87,336 - $108,221	1,909 Added 3.97%	49,987 $2.59 Million
Q4 2021 Jan 28, 2022	SELL	$41.32 - $61.25 $20,660 - $30,625	-500 Reduced 1.03%	48,078 $2.84 Million
Q3 2021 Oct 22, 2021	SELL	$39.25 - $50.42 $176,036 - $226,133	-4,485 Reduced 8.45%	48,578 $2.09 Million
Q1 2021 Apr 22, 2021	SELL	$33.49 - $37.77 $4.33 Million - $4.88 Million	-129,147 Reduced 70.88%	53,063 $1.92 Million
Q4 2020 Jan 27, 2021	SELL	$33.47 - $42.56 $2.79 Million - $3.54 Million	-83,251 Reduced 31.36%	182,210 $6.71 Million
Q3 2020 Oct 23, 2020	SELL	$31.75 - $37.25 $2.27 Million - $2.66 Million	-71,498 Reduced 21.22%	265,461 $9.74 Million
Q2 2020 Jul 24, 2020	SELL	$30.12 - $36.54 $331,952 - $402,707	-11,021 Reduced 3.17%	336,959 $10.5 Million
Q1 2020 Apr 22, 2020	SELL	$27.03 - $38.62 $3.59 Million - $5.13 Million	-132,742 Reduced 27.61%	347,980 $10.8 Million
Q4 2019 Jan 24, 2020	BUY	$32.92 - $37.36 $602,863 - $684,173	18,313 Added 3.96%	480,722 $18.8 Million
Q3 2019 Oct 30, 2019	SELL	$32.49 - $42.13 $2.01 Million - $2.6 Million	-61,781 Reduced 11.79%	462,409 $15.8 Million
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $297,060 - $333,530	-8,033 Reduced 1.51%	524,190 $22.7 Million
Q1 2019 Apr 26, 2019	SELL	$37.5 - $41.2 $899,362 - $988,099	-23,983 Reduced 4.31%	532,223 $22.6 Million
Q4 2018 Jan 22, 2019	SELL	$38.47 - $43.86 $3.91 Million - $4.46 Million	-101,680 Reduced 15.46%	556,206 $24.3 Million
Q3 2018 Oct 26, 2018	SELL	$34.47 - $41.81 $1.67 Million - $2.02 Million	-48,350 Reduced 6.85%	657,886 $29 Million
Q2 2018 Jul 19, 2018	BUY	$32.98 - $35.16 $98,939 - $105,479	3,000 Added 0.43%	706,236 $25.6 Million
Q1 2018 Apr 12, 2018	SELL	$31.91 - $37.02 $1.64 Million - $1.91 Million	-51,520 Reduced 6.83%	703,236 $25 Million
Q4 2017 Jan 23, 2018	SELL	$33.26 - $35.29 $37,118 - $39,383	-1,116 Reduced 0.15%	754,756 $27.3 Million
Q3 2017 Oct 13, 2017	BUY	$31.0 - $34.15 $23.4 Million - $25.8 Million	755,872	755,872 $27 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.

Account

James Investment Research Inc Pfizer Inc Transaction History